The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Aadi Bioscience Inc | Common | 00032Q104 | 6,538 | 509,572 | SH | SOLE | 509,572 | 0 | 0 | |||
Aclaris Therapeutics, Inc. | Common | 00461U105 | 14,153 | 898,631 | SH | SOLE | 898,631 | 0 | 0 | |||
Aligos Therapeutics Inc | Common | 01626L105 | 3,380 | 3,547,030 | SH | SOLE | 3,547,030 | 0 | 0 | |||
Allakos Inc | Common | 01671P100 | 34,692 | 4,120,134 | SH | SOLE | 4,120,134 | 0 | 0 | |||
ALX Oncology Holdings Inc | Common | 00166B105 | 47,560 | 4,220,048 | SH | SOLE | 4,220,048 | 0 | 0 | |||
Amyris, Inc | Common | 03236M200 | 11,859 | 7,750,828 | SH | SOLE | 7,750,828 | 0 | 0 | |||
Arrowhead Pharmaceuticals Inc | Common | 04280A100 | 5,573 | 137,411 | SH | SOLE | 137,411 | 0 | 0 | |||
Aslan Pharmaceuticals Ltd | ADS | 04522R101 | 1,023 | 2,840,909 | SH | SOLE | 2,840,909 | 0 | 0 | |||
Astria Therapeutics Inc | Common | 04635X102 | 25,033 | 1,681,199 | SH | SOLE | 1,681,199 | 0 | 0 | |||
Avadel Pharmaceuticals PLC | ADR | 05337M104 | 19,719 | 2,754,095 | SH | SOLE | 2,754,095 | 0 | 0 | |||
Bellus Health Inc | Common | 07987C204 | 8,361 | 1,017,152 | SH | SOLE | 1,017,152 | 0 | 0 | |||
BioAtla Inc | Common | 09077B104 | 5,257 | 637,181 | SH | SOLE | 637,181 | 0 | 0 | |||
Bolt Therapeutics Inc | Common | 097702104 | 5,033 | 3,871,291 | SH | SOLE | 3,871,291 | 0 | 0 | |||
Chinook Therapeutics Inc | Common | 16961L106 | 22,850 | 872,151 | SH | SOLE | 872,151 | 0 | 0 | |||
Cincor Pharma Inc | Common | 17240Y109 | 5,182 | 421,635 | SH | SOLE | 421,635 | 0 | 0 | |||
Codexis, Inc | Common | 192005106 | 1,809 | 388,144 | SH | SOLE | 388,144 | 0 | 0 | |||
Cogent Biosciences Inc | Common | 19240Q201 | 23,062 | 1,994,941 | SH | SOLE | 1,994,941 | 0 | 0 | |||
Compass Therapeutics Inc | Common | 20454B104 | 17,895 | 3,557,630 | SH | SOLE | 3,557,630 | 0 | 0 | |||
DBV Technologies SA | Sponsored ADR | 23306J101 | 4,145 | 2,708,875 | SH | SOLE | 2,708,875 | 0 | 0 | |||
Dyne Therapeutics Inc | Common | 26818M108 | 6,695 | 577,642 | SH | SOLE | 577,642 | 0 | 0 | |||
Genetron Holdings Ltd | ADS | 37186H100 | 9,099 | 8,124,174 | SH | SOLE | 8,124,174 | 0 | 0 | |||
Geron Corp | Common | 374163103 | 46,664 | 19,282,834 | SH | SOLE | 19,282,834 | 0 | 0 | |||
Gracell Biotechnologies Inc | SPONSORED ADS | 38406L103 | 2,211 | 961,358 | SH | SOLE | 961,358 | 0 | 0 | |||
Harmony Biosciences Holdings Inc | Common | 413197104 | 143,604 | 2,606,247 | SH | SOLE | 2,606,247 | 0 | 0 | |||
Homology Medicines, Inc. | Common | 438083107 | 466 | 370,068 | SH | SOLE | 370,068 | 0 | 0 | |||
Immunic Inc | Common | 4525EP101 | 833 | 632,184 | SH | SOLE | 632,184 | 0 | 0 | |||
Impel NeuroPharma Inc | Common | 45258K109 | 43,272 | 2,884,789 | SH | SOLE | 2,884,789 | 0 | 0 | |||
Instil Bio Inc | Common | 45783C101 | 7,867 | 12,486,787 | SH | SOLE | 12,486,787 | 0 | 0 | |||
IO Biotech Inc | Common | 449778109 | 6,936 | 3,015,545 | SH | SOLE | 3,015,545 | 0 | 0 | |||
Iovance Biotherapeutics Inc | Common | 462260100 | 4,186 | 655,057 | SH | SOLE | 655,057 | 0 | 0 | |||
KalVista Pharmaceuticals Inc. | Common | 483497103 | 5,787 | 856,008 | SH | SOLE | 856,008 | 0 | 0 | |||
Legend Biotech Corp Sponsored | SPONSORED ADS | 52490G102 | 12,199 | 244,375 | SH | SOLE | 244,375 | 0 | 0 | |||
Merus NV | Common | N5749R100 | 6,785 | 438,590 | SH | SOLE | 438,590 | 0 | 0 | |||
Minerva Surgical Inc | Common | 60343F106 | 495 | 2,215,667 | SH | SOLE | 2,215,667 | 0 | 0 | |||
Olema Pharmaceuticals Inc | Common | 68062P106 | 4,139 | 1,689,515 | SH | SOLE | 1,689,515 | 0 | 0 | |||
Precision Biosciences Inc | Common | 74019P108 | 167 | 140,255 | SH | SOLE | 140,255 | 0 | 0 | |||
Rezolute Inc | Common | 76200L309 | 1,013 | 489,473 | SH | SOLE | 489,473 | 0 | 0 | |||
Sera Prognostics Inc | Common | 81749D107 | 2,339 | 1,856,011 | SH | SOLE | 1,856,011 | 0 | 0 | |||
Sinovac Biotech Ltd. | SHS | P8696W104 | 38,173 | 5,900,000 | SH | SOLE | 5,900,000 | 0 | 0 | |||
Tarsus Pharmaceuticals Inc | Common | 87650L103 | 33,164 | 2,262,200 | SH | SOLE | 2,262,200 | 0 | 0 | |||
Terns Pharmaceuticals Inc | Common | 880881107 | 67,778 | 6,657,992 | SH | SOLE | 6,657,992 | 0 | 0 | |||
Vaxcyte Inc | Common | 92243G108 | 27,787 | 579,508 | SH | SOLE | 579,508 | 0 | 0 | |||
VectivBio Holding AG | Common | H9060V101 | 20,218 | 2,333,300 | SH | SOLE | 2,333,300 | 0 | 0 | |||
Ventyx Biosciences Inc | Common | 92332V107 | 42,735 | 1,303,294 | SH | SOLE | 1,303,294 | 0 | 0 | |||
Vera Therapeutics Inc | Common | 92337R101 | 7,753 | 400,666 | SH | SOLE | 400,666 | 0 | 0 | |||
Verona Pharma PLC | ADS | 925050106 | 3,637 | 4,249,918 | SH | SOLE | 4,249,918 | 0 | 0 | |||
Viridian Therapeutics Inc | Common | 92790C104 | 49,020 | 1,678,207 | SH | SOLE | 1,678,207 | 0 | 0 | |||
Zai Lab Ltd ADR | ADR | 98887Q104 | 10,399 | 338,721 | SH | SOLE | 338,721 | 0 | 0 |